ALLERGAN PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+1.73% | +0.97% |
Presenter SpeechDavid Maris (Analysts)I will come join you on the couch in a second, but I do ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Allergan plc is an Ireland-based pharmaceutical company. The Company is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. The Company's products primarily focus on four key therapeutic areas, including medical aesthetics, eye care, central nervous system and gastroenterology.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +0.97% | 63.66B | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
- Stock Market
- Equities
- AGN Stock
- News Allergan plc
- Transcript : Allergan plc Presents at 2018 Wells Fargo Securities Healthcare Conference, Sep-05-2018 09
